NCT03569189

Brief Summary

This study will investigate the effect of a 7-day westernised high-fat (65% of kilocalories), high-calorie (150% of requirements) diet on markers of inflammation in the blood and white adipose tissue. Participants will firstly complete a 3-day weight maintenance phase (Days 1-3) before completing a 7-day high fat diet intervention (Days 4-10). On days 4 and 11 participants will complete a laboratory visit where anthropometric measurements, blood and adipose samples will be collected. The investigators hypothesise that consuming a high-fat, high-calorie diet for 7 days will alter the inflammatory responses in white adipose tissue and will induce metabolic endotoxaemia / systemic inflammation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 26, 2018

Completed
6 days until next milestone

Study Start

First participant enrolled

July 2, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 23, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 23, 2018

Completed
Last Updated

January 4, 2019

Status Verified

January 1, 2019

Enrollment Period

5 months

First QC Date

May 22, 2018

Last Update Submit

January 3, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Protein expression (content and phosphorylation) of key markers of metabolic inflammation in white adipose tissue (for example assessment of NFKB/IKBa total protein and phosphorylation by western blot analysis)

    This will be assessed following the collection of fasted white adipose tissue samples

    Change between pre- and post-high fat diet (assessed on days 4 and 11)

Secondary Outcomes (8)

  • Systemic Markers of Inflammation (for example CRP, TNFa and IL-6 concentrations, determined by spectrophotometric assay/ ELISA)

    Change between pre- and post-high fat diet (assessed on days 4 and 11)

  • Gene expression of key markers of metabolic inflammation in white adipose tissue

    Change between pre- and post-high fat diet (assessed on days 4 and 11)

  • Fasting Serum Markers of Insulin Resistance (for example insulin and glucose concentrations, determined using an ELISA/ spectrophotometric assay)

    Change between pre- and post-high fat diet (assessed on days 4 and 11)

  • Fasting Serum Lipid Profile (for example total, HDL and LDL cholesterol, TAG and NEFA concentrations, measured using a spectrophotometric assay)

    Change between pre- and post-high fat diet (assessed on days 4 and 11)

  • Systemic Markers of Metabolic Endotoxemia (for example LBP and sCD14 concentrations, determined using an ELISA)

    Change between pre- and post-high fat diet (assessed on days 4 and 11)

  • +3 more secondary outcomes

Study Arms (1)

High Fat Diet

EXPERIMENTAL

Participants will consume a high-fat, high-calorie diet for 7 days (i.e. westernised diet) following a 3-day weight maintenance diet. Measurements will be made pre- and post-high fat diet intervention.

Other: High Fat Diet

Interventions

Participants will consume a high fat diet for 7 days with 65% of energy from fat. The diet will also provide an energy excess at 150% of energy requirements. Participants will be provided with all of their meals and snacks throughout the study.

High Fat Diet

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years
  • BMI = 21.0-29.9 kg/m2
  • Male or female
  • Physically active (\> 3 x 30 min moderate exercise per week)
  • Healthy
  • No cardiometabolic (e.g. heart disease, high blood pressure, type 2 diabetes) or inflammatory illness

You may not qualify if:

  • Inactive (\< 3 x 30 min moderate exercise per week)
  • Smoker
  • Women who are pregnant or lactating
  • Medication/supplements known to interfere with study outcomes or prescribed antibiotics within the last 3 months
  • Unstable weight history (≥3kg loss or gain in the previous 3 months)
  • An allergy to lidocaine
  • Food allergies (e.g. gluten, dairy) and intolerances (e.g. lactose) which could impede compliance to the diet
  • Vegetarian/ vegan (as the high-fat diet is based on animal fats)
  • Consumption of probiotics yogurts during or within the four weeks prior to the start of the study (e.g. Actimel, Activia, Yakult, Yeo Valley)
  • Alcohol consumption \>28 units per week for a man (i.e. not more than 14 pints of beer or 28 small glasses of wine) or \>21 units per week for a woman (i.e. more than 10 and a half pints of beer or 21 small glasses of wine)
  • Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention or metabolic study
  • Restrained eaters (determined by Three Factor Eating Questionnaire)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loughborough University

Loughborough, Leicestershire, LE11 3TU, United Kingdom

Location

Related Publications (1)

  • Dewhurst-Trigg R, Wadley AJ, Woods RM, Sherar LB, Bishop NC, Hulston CJ, Markey O. Short-term High-fat Overfeeding Does Not Induce NF-kappaB Inflammatory Signaling in Subcutaneous White Adipose Tissue. J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa158. doi: 10.1210/clinem/dgaa158.

MeSH Terms

Conditions

InflammationObesityCardiovascular Diseases

Interventions

Diet, High-Fat

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and Symptoms

Intervention Hierarchy (Ancestors)

DietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Oonagh Markey, BSc, PhD

    Loughborough University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 22, 2018

First Posted

June 26, 2018

Study Start

July 2, 2018

Primary Completion

November 23, 2018

Study Completion

November 23, 2018

Last Updated

January 4, 2019

Record last verified: 2019-01

Locations